BTG PLC (BTG.L)
(Adds forecast, analyst comment, share movement) May 17 British healthcare group BTG Plc said its full-year pretax profit doubled from a year earlier as sales of its interventional therapies picked up, and forecast an 8-15 percent revenue growth for the next year. BTG shares rose as much as 2.4 percent to 600.50 pence on Tuesday morning. BTG said it expected revenue to be in the range 485 million pounds to 515 million pounds ($703.6 million-$746.7 million) for the fin
May 17 British healthcare group BTG said its full-year pretax profit doubled from a year earlier on strong revenue growth.
* Galil Medical announces agreement to acquisition by Btg Plc Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
LONDON British healthcare group BTG said is had agreed to buy Galil Medical, a U.S. company that makes cryoablation products to treat Kidney and other cancers by freezing and destroying tumors, for an initial cash payment of $84.5 million.
LONDON After being vindicated in her 2014 purchase of a U.S. company with a device to prop open diseased lungs, the chief executive of British healthcare group BTG is scouring the horizon for the next promising acquisition.
LONDON Specialist medicine company BTG received a triple dose of good news on Monday as U.S. regulators approved two new treatments and a clinical trial of a novel lung device produced positive results.